Switch to:
Alexion Pharmaceuticals Inc (NAS:ALXN)
EV/Revenue
10.24 (As of Today)

EV/Revenue ratio is calculated as enterprise value divided by its revenue. As of today, Alexion Pharmaceuticals Inc's enterprise value is $27,706 Mil. Alexion Pharmaceuticals Inc's revenue for the trailing twelve months (TTM) ended in Mar. 2016 was $2,705 Mil. Therefore, Alexion Pharmaceuticals Inc's EV/Revenue ratio for today is 10.24.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today, Alexion Pharmaceuticals Inc's stock price is $112.99. Alexion Pharmaceuticals Inc's revenue per share for the trailing twelve months (TTM) ended in Mar. 2016 was $12.39. Therefore, Alexion Pharmaceuticals Inc's P/S Ratio for today is 9.12.


Definition

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Alexion Pharmaceuticals Inc's EV/Revenue for today is calculated as:

EV/Revenue=Enterprise Value (Today)/Revenue (TTM)
=27705.586/2704.752
=10.24

Alexion Pharmaceuticals Inc's current Enterprise Value is $27,706 Mil.
Alexion Pharmaceuticals Inc's Revenue for the trailing twelve months (TTM) ended in Mar. 2016 was 636.21 (Jun. 2015 ) + 666.637 (Sep. 2015 ) + 700.867 (Dec. 2015 ) + 701.038 (Mar. 2016 ) = $2,705 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Alexion Pharmaceuticals Inc's P/S Ratio for today is calculated as:

P/S Ratio=Share Price (Today)/Revenue Per Share (TTM)
=112.99/12.393
=9.12

Alexion Pharmaceuticals Inc's share price for today is $112.99.
Alexion Pharmaceuticals Inc's Revenue Per Share for the trailing twelve months (TTM) ended in Mar. 2016 was 3.11 (Jun. 2015 ) + 2.947 (Sep. 2015 ) + 3.246 (Dec. 2015 ) + 3.09 (Mar. 2016 ) = $12.39.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Revenue, P/S Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Alexion Pharmaceuticals Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2rev 894.9940.6310.9110.8012.9716.2415.3515.9915.6817.38

Alexion Pharmaceuticals Inc Quarterly Data

Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16
ev2rev 15.9916.1515.3415.0615.6814.4817.9615.0017.3812.43
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK